WO2003106972A3 - Multiple domain tdf-related compounds and analogs thereof - Google Patents

Multiple domain tdf-related compounds and analogs thereof Download PDF

Info

Publication number
WO2003106972A3
WO2003106972A3 PCT/US2003/019229 US0319229W WO03106972A3 WO 2003106972 A3 WO2003106972 A3 WO 2003106972A3 US 0319229 W US0319229 W US 0319229W WO 03106972 A3 WO03106972 A3 WO 03106972A3
Authority
WO
WIPO (PCT)
Prior art keywords
tdf
analogs
related compounds
multiple domain
relates
Prior art date
Application number
PCT/US2003/019229
Other languages
French (fr)
Other versions
WO2003106972A2 (en
Inventor
William D Carlson
Peter C Keck
Original Assignee
Thrasos Inc
William D Carlson
Peter C Keck
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thrasos Inc, William D Carlson, Peter C Keck filed Critical Thrasos Inc
Priority to AU2003276752A priority Critical patent/AU2003276752A1/en
Publication of WO2003106972A2 publication Critical patent/WO2003106972A2/en
Publication of WO2003106972A3 publication Critical patent/WO2003106972A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention relates generally to tissue differentiation factor (TDF) analogs. More specifically, the invention relates to structure-based methods and compositions useful in designing, identifying, and producing molecules which act as functional modulators of TDF-like receptors. The invention further relates to methods of detecting, preventing, and treating TDF-associated disorders.
PCT/US2003/019229 2002-06-17 2003-06-17 Multiple domain tdf-related compounds and analogs thereof WO2003106972A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003276752A AU2003276752A1 (en) 2002-06-17 2003-06-17 Multiple domain tdf-related compounds and analogs thereof

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US38949002P 2002-06-17 2002-06-17
US38948602P 2002-06-17 2002-06-17
US60/389,490 2002-06-17
US60/389,486 2002-06-17
US44172403P 2003-01-22 2003-01-22
US60/441,724 2003-01-22
US45872703P 2003-03-28 2003-03-28
US45885103P 2003-03-28 2003-03-28
US60/458,727 2003-03-28
US60/458,851 2003-03-28

Publications (2)

Publication Number Publication Date
WO2003106972A2 WO2003106972A2 (en) 2003-12-24
WO2003106972A3 true WO2003106972A3 (en) 2004-09-30

Family

ID=29741151

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/019229 WO2003106972A2 (en) 2002-06-17 2003-06-17 Multiple domain tdf-related compounds and analogs thereof

Country Status (2)

Country Link
AU (1) AU2003276752A1 (en)
WO (1) WO2003106972A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2789342A1 (en) 2004-06-17 2014-10-15 Thrasos Innovation, Inc. TDF-related compounds and analogs thereof
AU2012200042B2 (en) * 2004-06-17 2015-03-26 Thrasos Innovation, Inc. TDF-related compounds and analogs thereof
AU2012201060B2 (en) * 2005-09-20 2015-01-22 Thrasos Innovation, Inc. TDF-related compounds and analogs thereof
CA2863125A1 (en) 2005-09-20 2007-03-29 Thrasos Innovation, Inc. Tdf-related compounds and analogs thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CELESTE A.J. ET AL: "Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCE OF THE USA, vol. 87, no. 24, December 1990 (1990-12-01), WASHINGTON, DC, US, pages 9843 - 9847, XP000168624 *

Also Published As

Publication number Publication date
AU2003276752A8 (en) 2003-12-31
AU2003276752A1 (en) 2003-12-31
WO2003106972A2 (en) 2003-12-24

Similar Documents

Publication Publication Date Title
WO2006009836A3 (en) Tdf-related compounds and analogs thereof
HUS2100051I1 (en) Compositions and methods of treating cell proliferation disorders
WO2007035872A3 (en) Tdf-related compounds and analogs thereof
MXPA04006280A (en) Spiroazacyclic compounds as monoamine receptor modulators.
TW200510301A (en) Novel compounds
TW200510303A (en) Novel compounds
TW200407305A (en) Novel compounds
SG170828A1 (en) Deazapurines useful as inhibitors of janus kinases
EA200900828A1 (en) COMPOUNDS AND COMPOSITIONS AS AN INHIBITOR ACTIVITY OF THE CANANABINOID RECEPTOR 1
GEP20084550B (en) Substituted morpholine compounds for the treatment of central nervous system disorders
GB0510143D0 (en) Novel compounds A1
MY145070A (en) Imidazolothiazole compounds for the treatment of disease
NO20060402L (en) 3-amino choman and 2-aminotetraline derivatives
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
SE0203713D0 (en) Novel compounds
GEP20074197B (en) 5ht2c receptor modulators
BR0308339A (en) Indazoles Replaced with Anticancer Activity
MX2009005455A (en) (r)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs.
HK1096673A1 (en) Compositions useful as inhibitors of protein kinases
MX2009002377A (en) Indazole derivatives as modulators of interleukin- 1 receptor-associated kinase.
NO20071742L (en) Kinazolins useful as modulators of ion channels
MXPA06003363A (en) Phenyl-piperazine derivatives as modulators of muscarinic receptors.
TW200745088A (en) Benzimidazoles useful as inhibitors of protein kinases
TW200510367A (en) Novel lapachone compounds, their preparation, and the use thereof
ATE435858T1 (en) PRODRUGS OF PYRROLYLPYRIMIDINES ACTING AS ERK PROTEIN KINASE INHIBITORS

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP